Description

Trenaxa (Tranexamic Acid) Solution for Injections 100 mg/ml. 5 ml. Vials №5

Ingredients

Each 5 ml vial contains 500 mg of Tranexamic Acid as the active ingredient.

Dosage

The usual dosage of Trenaxa is 10 mg/kg body weight administered intravenously. The dosage may vary based on the condition being treated.

Indications

Trenaxa is indicated for the treatment of various conditions such as:

• Excessive bleeding during surgery
• Menstrual bleeding disorders
• Hereditary angioedema

Contraindications

Do not use Trenaxa if:

• You are allergic to Tranexamic Acid
• You have a history of blood clots
• You are at risk of thromboembolic events

Directions

Trenaxa should be administered by healthcare professionals via intravenous injection. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Tranexamic Acid has been extensively studied for its hemostatic effects and is widely used in various medical specialties. Research published in the Journal of Trauma and Acute Care Surgery demonstrated the efficacy of Tranexamic Acid in reducing blood loss and transfusion requirements in trauma patients.

Additional Information

Trenaxa is a valuable tool in managing bleeding disorders and reducing the need for blood transfusions. Its mechanism of action involves inhibiting the breakdown of blood clots, thereby promoting clot formation and reducing bleeding. Clinical trials have shown promising results in improving patient outcomes and reducing complications associated with excessive bleeding.